Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Abstract excerpt

Advances in high-throughput DNA sequencing technology in the past decade have made a tremendous impact on basic science and clinical practice. Methods using the latest next generation sequencing technology can sequence an entire human genome within a few hours. Diagnosis and prognostication of hematologic neoplasms have moved from traditional histology and immunophenotyping to integration of cytogenetic and...

Topics

Join the communities discussing this publication.

• Genomics
• High-Throughput Nucleotide Sequencing
• Leukemia, Myeloid, Acute
• Mutation
• Myelodysplastic Syndromes